scholarly journals Local excision after polypectomy for rectal polyp cancer: when is it worthwhile?

2020 ◽  
Author(s):  
Helen J. S. Jones ◽  
Issam al‐Najami ◽  
Gunnar Baatrup ◽  
Chris Cunningham
Keyword(s):  
Local Excision ◽  
Rectal Polyp

Local excision of rectal polyp: indications and techniques

2004 ◽  
Vol 8 (S2) ◽  
pp. s300-s304 ◽  
Author(s):  
C. Fucini ◽  
D. Segre ◽  
M. Trompetto
Keyword(s):  
Local Excision ◽  
Rectal Polyp

Local Control of Local Excision for T1/T2 Rectal Cancer

2007 ◽  
Vol 23 (2) ◽  
pp. 87 ◽  
Author(s):  
Ki-Jae Park ◽  
Hong-Jo Choi ◽  
Young-Hoon Roh ◽  
Jong-Sok Shin ◽  
Hyung-Sik Lee
Keyword(s):  
Rectal Cancer ◽  
Local Excision ◽  
Local Control ◽  
T2 Rectal Cancer

Maxillary Melanotic Neuroectodermal Tumour of Infancy Managed by Local Excision

2021 ◽  
Author(s):  
Ashwitha Shenoy ◽  
Prasanth Penumadu ◽  
Friji Meethale Thiruvoth ◽  
Krishna Kumar Govindarajan
Keyword(s):  
Local Excision ◽  
Neuroectodermal Tumour

Pneumoperitoneum, Pneumoretroperitoneum, and Pneumoscrotum Following Transanal Excision of Rectal Polyp

2020 ◽  
pp. 000313482095635
Author(s):  
Michaelia S. Sunderland ◽  
Anthony Dakwar ◽  
Anupam Rishi ◽  
Robert D. Bennett
Keyword(s):  
Rectal Polyp ◽  
Transanal Excision

Influence of Histomorphological Parameters and Ploidy on Recurrence-Free Survival Time in Early Rectal Cancer after Local Excision

1993 ◽  
Vol 10 (6) ◽  
pp. 300-305
Author(s):  
T. Böttger ◽  
A. Heinz ◽  
D. Potratz ◽  
M. Stöckle ◽  
T. Junginger
Keyword(s):  
Rectal Cancer ◽  
Survival Time ◽  
Local Excision ◽  
Recurrence Free Survival ◽  
Early Rectal Cancer ◽  
Free Survival

scholarly journals Conjunctival melanoma treatment outcomes in 288 patients: a multicentre international data-sharing study

2020 ◽  
pp. bjophthalmol-2020-316293
Author(s):  
Puneet Jain ◽  
Paul T Finger ◽  
Maria Fili ◽  
Bertil Damato ◽  
Sarah E Coupland ◽  
...  
Keyword(s):  
Local Recurrence ◽  
Local Excision ◽  
External Beam Radiotherapy ◽  
Staging System ◽  
Primary Treatment ◽  
Excision Biopsy ◽  
Conjunctival Melanoma ◽  
Recurrence Rates ◽  
Increased Risk ◽  
Eighth Edition

BackgroundTo relate conjunctival melanoma characteristics to local control.MethodsRetrospective, registry-based interventional study with data gathered from 10 ophthalmic oncology centres from 9 countries on 4 continents. Conjunctival melanoma patients diagnosed between January 2001 and December 2013 were enrolled in the study. Primary treatments included local excision, excision with cryotherapy and exenteration. Adjuvant treatments included topical chemotherapy, brachytherapy, proton and external beam radiotherapy (EBRT). Cumulative 5-year and 10-year Kaplan-Meier local recurrence rates were related to clinical and pathological T-categories of the eighth edition of the American Joint Committee on Cancer (AJCC) staging system.Results288 patients had a mean initial age of 59.7±16.8 years. Clinical T-categories (cT) were cT1 (n=218,75.7%), cT2 (n=34, 11.8%), cT3 (n=15, 5.2%), cTx (n=21,7.3%) with no cT4. Primary treatment included local excision (n=161/288, 55.9%) followed by excision biopsy with cryotherapy (n=108/288, 37.5%) and exenteration (n=5/288, 1.7%). Adjuvant therapies included topical mitomycin (n=107/288, 37.1%), plaque-brachytherapy (n=55/288, 19.1%), proton-beam (n=36/288, 13.5%), topical interferon (n=20/288, 6.9%) and EBRT (n=15/288, 5.2%). Secondary exenteration was performed (n=11/283, 3.9%). Local recurrence was noted in 19.1% (median=3.6 years). Cumulative local recurrence was 5.4% (3.2–8.9%), 19.3% (14.4–25.5%) and 36.9% (26.5–49.9%) at 1, 5 and 10 years, respectively. cT3 and cT2 tumors were twice as likely to recur than cT1 tumours, but only cT3 had statistically significantly greater risk of local recurrence than T1 (p=0.013). Factors such as tumour ulceration, plica or caruncle involvement and tumour thickness were not significantly associated with an increased risk of local recurrence.ConclusionThis multicentre international study showed that eighth edition of AJCC tumour staging was related to the risk of local recurrence of conjunctival melanoma after treatment. The 10-year cumulative local recurrence remains high despite current management.

Sign in / Sign up

Export Citation Format

Share Document